Accolade Stock Performance
ACCD Stock | USD 6.99 0.01 0.14% |
Accolade holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.3, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Accolade are expected to decrease by larger amounts. On the other hand, during market turmoil, Accolade is expected to outperform it. Use Accolade jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to analyze future returns on Accolade.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Accolade are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Accolade exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.14) | Year To Date Return 104.39 | Ten Year Return 1.2 K | All Time Return 1.2 K |
1 | Disposition of 389 shares by Richard Eskew of Accolade subject to Rule 16b-3 | 01/02/2025 |
2 | Disposition of 3 shares by Richard Eskew of Accolade at 3.407 subject to Rule 16b-3 | 01/03/2025 |
3 | Disposition of 541 shares by Rajeev Singh of Accolade at 6.879 subject to Rule 16b-3 | 01/13/2025 |
4 | Disposition of 415 shares by Barnes Stephen H. of Accolade subject to Rule 16b-3 | 01/16/2025 |
5 | Disposition of 154 shares by Barnes Stephen H. of Accolade at 6.859 subject to Rule 16b-3 | 01/17/2025 |
6 | Acquisition by Kent Cindy of 1406 shares of Accolade subject to Rule 16b-3 | 01/30/2025 |
7 | Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering | 02/04/2025 |
8 | Acquisition by Robert Cavanaugh of 1569 shares of Accolade subject to Rule 16b-3 | 02/07/2025 |
9 | Disposition of 770 shares by Barnes Stephen H. of Accolade subject to Rule 16b-3 | 02/10/2025 |
10 | Disposition of 221 shares by Barnes Stephen H. of Accolade at 6.885 subject to Rule 16b-3 | 02/11/2025 |
11 | Disposition of 933 shares by Rajeev Singh of Accolade subject to Rule 16b-3 | 02/18/2025 |
12 | Disposition of 279 shares by Rajeev Singh of Accolade at 6.901 subject to Rule 16b-3 | 02/19/2025 |
13 | Accolade president Robert Cavanaugh sells 1,242 in stock - Investing.com | 02/20/2025 |
14 | Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending ... | 02/24/2025 |
15 | Cathie Woods ARK buys Salesforce, Deere stock sells Spotify, Accolade - Investing.com | 02/27/2025 |
16 | Disposition of 2178 shares by Nabel Elizabeth G of Accolade subject to Rule 16b-3 | 02/28/2025 |
17 | Disposition of 388 shares by Richard Eskew of Accolade subject to Rule 16b-3 | 03/03/2025 |
18 | Has Accolade Outpaced Other Business Services Stocks This Year | 03/04/2025 |
19 | Disposition of 1569 shares by Robert Cavanaugh of Accolade subject to Rule 16b-3 | 03/05/2025 |
20 | Disposition of 1650 shares by Rajeev Singh of Accolade subject to Rule 16b-3 | 03/10/2025 |
21 | Disposition of 490 shares by Rajeev Singh of Accolade at 6.965 subject to Rule 16b-3 | 03/11/2025 |
22 | Acquisition by Barnes Stephen H. of 770 shares of Accolade subject to Rule 16b-3 | 03/14/2025 |
Begin Period Cash Flow | 321.1 M |
Accolade |
Accolade Relative Risk vs. Return Landscape
If you would invest 332.00 in Accolade on December 19, 2024 and sell it today you would earn a total of 368.00 from holding Accolade or generate 110.84% return on investment over 90 days. Accolade is currently generating 1.8324% in daily expected returns and assumes 13.6864% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Accolade, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Accolade Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Accolade's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Accolade, and traders can use it to determine the average amount a Accolade's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1339
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ACCD | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
13.69 actual daily | 96 96% of assets are less volatile |
Expected Return
1.83 actual daily | 36 64% of assets have higher returns |
Risk-Adjusted Return
0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Accolade is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Accolade by adding it to a well-diversified portfolio.
Accolade Fundamentals Growth
Accolade Stock prices reflect investors' perceptions of the future prospects and financial health of Accolade, and Accolade fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Accolade Stock performance.
Return On Equity | -0.48 | ||||
Return On Asset | -0.075 | ||||
Profit Margin | (0.40) % | ||||
Operating Margin | (0.23) % | ||||
Current Valuation | 584.16 M | ||||
Shares Outstanding | 81.68 M | ||||
Price To Book | 1.83 X | ||||
Price To Sales | 1.28 X | ||||
Revenue | 414.29 M | ||||
Gross Profit | 215.08 M | ||||
EBITDA | (69.29 M) | ||||
Net Income | (99.81 M) | ||||
Cash And Equivalents | 330.63 M | ||||
Cash Per Share | 4.60 X | ||||
Total Debt | 241.65 M | ||||
Debt To Equity | 0.63 % | ||||
Current Ratio | 3.33 X | ||||
Book Value Per Share | 3.85 X | ||||
Cash Flow From Operations | (16.17 M) | ||||
Earnings Per Share | (2.28) X | ||||
Market Capitalization | 571.75 M | ||||
Total Asset | 788.15 M | ||||
Retained Earnings | (1.05 B) | ||||
Working Capital | 177.06 M | ||||
About Accolade Performance
By analyzing Accolade's fundamental ratios, stakeholders can gain valuable insights into Accolade's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Accolade has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Accolade has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | (29.86) | (28.37) | |
Return On Tangible Assets | (0.26) | (0.27) | |
Return On Capital Employed | (0.15) | (0.16) | |
Return On Assets | (0.11) | (0.12) | |
Return On Equity | (0.26) | (0.24) |
Things to note about Accolade performance evaluation
Checking the ongoing alerts about Accolade for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Accolade help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Accolade is way too risky over 90 days horizon | |
Accolade appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 215.08 M. | |
Accolade currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6. | |
Accolade has a poor financial position based on the latest SEC disclosures | |
Over 89.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from MacroaxisInsider: Disposition of 490 shares by Rajeev Singh of Accolade at 6.965 subject to Rule 16b-3 |
- Analyzing Accolade's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Accolade's stock is overvalued or undervalued compared to its peers.
- Examining Accolade's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Accolade's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Accolade's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Accolade's stock. These opinions can provide insight into Accolade's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Accolade Stock analysis
When running Accolade's price analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accolade is operating at the current time. Most of Accolade's value examination focuses on studying past and present price action to predict the probability of Accolade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accolade's price. Additionally, you may evaluate how the addition of Accolade to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |